Synthetic antibodies: concepts, potential and practical considerations.
about
Understanding FRET as a research tool for cellular studiesDirected Evolution of a Highly Specific FN3 Monobody to the SH3 Domain of Human Lyn Tyrosine Kinase.Affinity flow fractionation of cells via transient interactions with asymmetric molecular patterns.Identification of human single-chain antibodies with broad reactivity for noroviruses.Generating conformation-specific synthetic antibodies to trap proteins in selected functional statesOne-step zero-background IgG reformatting of phage-displayed antibody fragments enabling rapid and high-throughput lead identification.High-affinity recombinant antibody fragments (Fabs) can be applied in peptide enrichment immuno-MRM assays.Principles and application of antibody libraries for infectious diseases.Scalable high throughput selection from phage-displayed synthetic antibody libraries.Progress in the development of immunoanalytical methods incorporating recombinant antibodies to small molecular weight biotoxins.A New Versatile Immobilization Tag Based on the Ultra High Affinity and Reversibility of the Calmodulin-Calmodulin Binding Peptide Interaction.Predominant structural configuration of natural antibody repertoires enables potent antibody responses against protein antigensStreamlining the Pipeline for Generation of Recombinant Affinity Reagents by Integrating the Affinity Maturation Step.Rational design of antibodies targeting specific epitopes within intrinsically disordered proteins.Engineered Autonomous Human Variable DomainsA phosphorylation pattern-recognizing antibody specifically reacts to RNA polymerase II bound to exonsWhole Cell Panning with Phage Display.High-Throughput IgG Conversion of Phage Displayed Fab Antibody Fragments by AmplYFast.Targeted drug delivery for cancer therapy: the other side of antibodies.Designer protein delivery: From natural to engineered affinity-controlled release systems.Selective targeting of primary and secondary nucleation pathways in Aβ42 aggregation using a rational antibody scanning method.Facile Affinity Maturation of Antibody Variable Domains Using Natural Diversity Mutagenesis.SUMO as a nuclear hormone receptor effector: New insights into combinatorial transcriptional regulation.The use of phage display to generate conformation-sensor recombinant antibodies.Oxidized Carbon Black: Preparation, Characterization and Application in Antibody Delivery across Cell Membrane.Productive common light chain libraries yield diverse panels of high affinity bispecific antibodies.CMOS-Compatible Silicon Nanowire Field-Effect Transistor Biosensor: Technology Development toward Commercialization.The structure of the C-terminal domain of the nucleoprotein from the Bundibugyo strain of the Ebola virus in complex with a pan-specific synthetic Fab
P2860
Q28088633-233FD6B0-CD18-477E-98FC-78B1764A1E01Q30009044-F8823394-BC2B-4E32-B84A-969D7F5DE954Q30541964-E9364D60-ED46-4704-A095-203477C1C449Q34313167-559CC92E-7943-49A2-AB4E-849ED2A1F11DQ34528889-92DBF768-0078-4DAB-B676-89086E8010A0Q35047152-3FD147C8-B559-4D6B-A830-2EDAD0CA07F8Q35102677-63FF50E8-4226-4548-9442-E2AF531ECE80Q35249355-81017B58-D88B-46FD-B2AA-83B761875965Q35555100-38C0BA54-53A5-4294-BD1A-0375279528D0Q35567882-634CFB98-E538-4EDD-A4B1-0194B6AF832AQ35687367-D44BF3EC-C40C-487E-88CD-CFFFDFF14922Q35707409-52124F00-3F3B-4309-B32E-DFAA12D94BCBQ35799445-268D17E6-3C0A-45A7-A50A-0A65132EFAFFQ35961236-27998FBE-9C56-4998-A488-CBF5EFCE1C1BQ36140177-9FEF88D2-C3E1-400C-B923-73295DCD4602Q36195825-E2302DFD-0088-406F-B0C7-A4A935B40EEAQ36296232-181E0E72-442B-485C-84AD-18BD3A9F4D5CQ36296240-E99CD1C6-09EF-4680-9FED-0B00C0432B0CQ38058816-B930E4C7-1474-4AC2-B813-ED91110DC3EEQ38293159-931A746A-669F-42E2-8CD1-008225D9582FQ41074700-21227F5B-E875-45D2-A4E4-D7F85891F4ACQ41472386-FEEDA140-99B9-4107-BCCF-03CD0A40BEE0Q42881081-58B5EF95-1CF7-4D03-BEF5-51BF41499369Q43090031-8DC288C8-D810-4FD0-AB86-3055257BB853Q48509485-54F1B0FC-0ABB-4054-A9C1-1B387819CA04Q49951608-322B7363-3B4F-4D12-8473-505D580BFE13Q54958898-35E5BA47-75EC-42B0-86D5-C6D1F332F1C8Q56345514-8C4E9CB5-4945-4BA6-994D-2645E94E9005
P2860
Synthetic antibodies: concepts, potential and practical considerations.
description
2012 nî lūn-bûn
@nan
2012 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Synthetic antibodies: concepts, potential and practical considerations.
@ast
Synthetic antibodies: concepts, potential and practical considerations.
@en
Synthetic antibodies: concepts, potential and practical considerations.
@nl
type
label
Synthetic antibodies: concepts, potential and practical considerations.
@ast
Synthetic antibodies: concepts, potential and practical considerations.
@en
Synthetic antibodies: concepts, potential and practical considerations.
@nl
prefLabel
Synthetic antibodies: concepts, potential and practical considerations.
@ast
Synthetic antibodies: concepts, potential and practical considerations.
@en
Synthetic antibodies: concepts, potential and practical considerations.
@nl
P1433
P1476
Synthetic antibodies: concepts, potential and practical considerations.
@en
P2093
P304
P356
10.1016/J.YMETH.2012.06.012
P577
2012-06-27T00:00:00Z